Xavier Quantin

11.3k citations
136 papers · 8.8k · 2 hit papers · h-index 30

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 42
    • Lung Cancer Diagnosis and Treatment 28
    • Brain Metastases and Treatment 6
    • Cancer Immunotherapy and Biomarkers 29
    • Lung Cancer Research Studies 16

Xavier Quantin

119 papers receiving 8.6k citations

Xavier Quantin's Hit Papers

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC 2018 · 2.2k citations
2.2k0+3+6Years since publication1k2k3k

Peers

Xavier Quantin
Comparison fields: 5 of 118
  • Oncology 4k
  • Pulmonary and Respiratory Medicine 3.6k
  • Radiation 260
  • Cancer Research 307
  • Otorhinolaryngology 114
Replace David Pérol with:
David Pérol France
Élisabeth Quoix France
Thierry Marie Jahan United States
Gregory Peter Kalemkerian United States
Nevin Murray Canada
Mark R. Green United States
Hideo Kunitoh Japan
Carol Jane Swallow Canada
Ikuo Sekine Japan
Tawee Tanvetyanon United States
Xavier Quantin relative to David Pérol France David Pérol's profile →
Citations per field
00.5×1.5×1.8×
David Pérol · 1×
Citations per year

Countries citing papers authored by Xavier Quantin

Since Specialization
Citations

This map shows the geographic impact of Xavier Quantin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Quantin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Quantin more than expected).

Fields of papers citing papers by Xavier Quantin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Quantin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Quantin. The network helps show where Xavier Quantin may publish in the future.

Co-authors

The 25 scholars most cited alongside Xavier Quantin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xavier Quantin Line = papers co-authored together Xavier Quantin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Hit paper breakdown →
20173582
2
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Hit paper breakdown →
20182246
3 2010262
4 2015182
5 2020133
6 2001124
7 2001108
8 2005108
9 2019101
10 202192
11 200189
12 202372
13 202367
14 199664
15 202163
16 202362
17 200160
18 201860
19 201943
20 199842

About Xavier Quantin

Xavier Quantin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Neurology and Cancer Research, having authored 136 papers that have together received 8.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (42 papers), Cancer Immunotherapy and Biomarkers (29 papers), Lung Cancer Diagnosis and Treatment (28 papers), Smoking Behavior and Cessation (19 papers), Lung Cancer Research Studies (16 papers), Myasthenia Gravis and Thymoma (9 papers), Cancer Genomics and Diagnostics (7 papers) and Brain Metastases and Treatment (6 papers). The work is most often cited by research in Oncology (4k citations), Pulmonary and Respiratory Medicine (3.6k citations), Radiation (260 citations), Cancer Research (307 citations) and Otorhinolaryngology (114 citations). Xavier Quantin has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean-Louis Pujol, Jean Louis Pujol, Jean Grenier, Jean‐Pierre Daurès, Jean‐Marie Boher, Isabelle Solassol, Frédéric Pinguet, Bernard Hedon, L. Reyftmann and Hervé Déchaud. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology, Cancers and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact